手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| Mixed Methods Appraisal Tool（混合手法評価ツール）：研究デザイン横断的な質評価× | PRISMAチェックリスト：システマティックレビューとメタアナリシスの報告基準× | |
|---|---|---|
| 分野 | 研究方法論 | 研究方法論 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2014 (updated 2018) | 2021 (original 2009) |
| 提唱者≠ | Pluye et al. | Page et al. (PRISMA Group) |
| 種類≠ | Research methodology evaluation | Systematic review author reporting checklist |
| 原典≠ | Pluye, P., & Hong, Q. N. (2014). Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annual Review of Public Health, 35, 29–45. DOI ↗ | Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. DOI ↗ |
| 別名 | MMAT, MMAT 2018 | PRISMA, PRISMA 2020 |
| 関連 | 4 | 4 |
| 概要≠ | MMAT (Mixed Methods Appraisal Tool) is a practical, design-agnostic quality assessment tool developed by Pluye et al. (2014, updated 2018) to evaluate the methodological quality of quantitative (RCTs, non-randomized studies), qualitative, and mixed-methods studies. Unlike tools designed for single paradigms (e.g., Cochrane RoB 2 for RCTs), MMAT provides unified criteria applicable across diverse research methodologies, making it particularly useful for systematic reviews incorporating multiple study designs. | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility. |
| ScholarGateデータセット ↗ |
|
|